Skip to content

Which Treatment Works Better for Trigger Finger: Steroid Injection or Needle Release

COMPARATIVE STUDY OF CORTICOSTEROID INJECTION VERSUS PERCUTANEOUS RELEASE IN MANAGEMENT OF TRIGGER FINGER: A RANDOMIZED CONTROL TRIAL - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113866
Enrollment
30
Registered
2026-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M653- Trigger finger

Interventions

Intervention1: patients diagnosed with trigger finger: given local injection corticosteroid(triamsilone 40mg) mixed with 1ml 2% lignocaine Control Intervention1: patients diagnosed with trigger finger

Sponsors

Chhattisgarh Institute of Medical Sciences,Bilaspur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged more than 18 to 60 years of either sex presenting with Clinical diagnosis of trigger finger of Quinnell grade equal to or more than 2. Willingness for treatment and regular follow up. No prior percutanoeus or steroid intervention

Exclusion criteria

Exclusion criteria: Patients with Grade 1 trigger finger. Patients with Post-traumatic or post-inflammatory arthritic fingers

Design outcomes

Primary

MeasureTime frame
1.To compare the functional outcomes of corticosteroid injection versus percutaneous release in patients with grade equal to or more than 2 trigger finger, using the VAS pain score, Quinnell grading and compression-confirming test. 2.To assess symptom improvement in terms of pain, triggering, and swelling over a follow up period of 3 weeks, 6 weeks, and 3 months Timepoint: 3 weeks, 6 weeks and 3 months

Secondary

MeasureTime frame
1. To document and compare the incidence of complications (e.g., infection, stiffness, scarrelated issues, paresthesia) in both treatment groups. 2. To determine the rate of recurrence and need for additional intervention during follow-up in both groups Timepoint: 3 weeks, 6 weeks and 3 months

Countries

India

Contacts

Public ContactDr PRAMOD JAISWAL

CHHATTISGARH INSTITUTE OF MEDICAL SCIENCES, BILASPUR (C.G.)

drarbenn@yahoo.com9425542352

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026